Skip to content

RxSight, Inc. RXST Market capitalization

Market capitalization at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$71.48M-57.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.84B+58.2%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
$47.98M+51.4%
Bausch + Lomb logo
Bausch + LombBLCO
$5.63B+10.2%
Glaukos logo
GlaukosGKOS
$6.25B+12.3%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Computed from the period-end share price: $254.2M.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s market capitalization?
RxSight, Inc. (RXST) reported market capitalization of $254.2M in Q1 2026.
How has RxSight, Inc.'s market capitalization changed year-over-year?
RxSight, Inc.'s market capitalization decreased by 75.1% year-over-year, from $1.02B to $254.2M.
What is the long-term trend for RxSight, Inc.'s market capitalization?
Over 4 years (2021 to 2025), RxSight, Inc.'s market capitalization has grown at a 8.6% compound annual growth rate (CAGR), from $308.54M to $428.44M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.